Volume 33 Number 4 (2024)

Outcome of Relapsed or Refractory Diffuse Large B-cell Lymphoma with Second-line Chemotherapy Ifosfamide-Carboplatin-Etoposide with or without Rituximab

Haque S1 , Chowdhury ZZ2 , Bahar T3 , Reshma ST4 , Islam AKM5 , Ali M6 , Rahman MM7

https://doi.org/10.XXXXX/mmj.2024.v3304.32

© 2025 Mymensingh Medical Journal. This content is for academic preview only. Reproduction, printing, or distribution is prohibited without permission.


Please follow the process to obtain PDF copy

For Domestic (Bangladesh)

Subscription Fee:

BDT 500 / article

Payment to:

MMJMMC Bank Account

For Subscription Email: [email protected]

email now
For Abroad

Subscription Fee:

USD 50 / article

Payment to:

MMJMMC Bank Account

For Subscription Email: [email protected]

email now